These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8965469)

  • 21. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
    Threlkeld AB; Assalian AA; Allingham RR; Shields MB
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.
    Onal S; Gozum N; Gucukoglu A
    Ophthalmic Surg Lasers Imaging; 2005; 36(6):457-62. PubMed ID: 16355950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
    Morrison JC; Robin AL
    Ophthalmology; 1989 Jan; 96(1):3-7. PubMed ID: 2645550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Iopidine in the control of intraocular pressure after glaucoma laser treatment].
    Stîngu C; Cristescu A; Dărăban C; Ioniţă M; Serghiescu S
    Oftalmologia; 2001; 54(4):32-5. PubMed ID: 12035597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
    Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
    Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.
    Robin AL; Coleman AL
    Trans Am Ophthalmol Soc; 1990; 88():149-59; discussion 159-62. PubMed ID: 1982747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats.
    Miller PE; Rhaesa SL
    Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.
    Shin DH; Glover BK; Cha SC; Kim YY; Kim C; Nguyen KD
    Am J Ophthalmol; 1999 May; 127(5):511-5. PubMed ID: 10334342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined use of apraclonidine and pilocarpine during laser iridotomy in a Hispanic population.
    Fernandez-Bahamonde JL; Alcaraz-Michelli V
    Ann Ophthalmol; 1990 Dec; 22(12):446-9. PubMed ID: 2078039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of 1% apraclonidine on intraocular pressure after cataract surgery.
    Sterk CC; Renzenbrink-Bubberman AC; van Best JA
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):472-5. PubMed ID: 9640568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes.
    Chung HS; Shin DH; Birt CM; Kim C; Lee D; Levin DS; Hakimzadeh R; Juzych MS
    Ophthalmology; 1997 Nov; 104(11):1921-5. PubMed ID: 9373127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.
    Gramer E; Busche S; Kampik A; Parsons D
    Graefes Arch Clin Exp Ophthalmol; 1995 Jan; 233(1):13-20. PubMed ID: 7721118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Apraclonidine prevents the acute increase of intraocular pressure in brown eyes with Nd:YAG laser iridectomy].
    Zhao J; Mao J; Liu X
    Zhonghua Yan Ke Za Zhi; 1998 May; 34(3):170-3. PubMed ID: 11877181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive effect of 1% apraclonidine hydrochloride to nonselective beta-blockers.
    Yaldo MK; Shin DH; Parrow KA; Lee SH; Lee SY
    Ophthalmology; 1991 Jul; 98(7):1075-8. PubMed ID: 1679916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of apraclonidine in long-term timolol users.
    Gharagozloo NZ; Brubaker RF
    Ophthalmology; 1991 Oct; 98(10):1543-6. PubMed ID: 1683697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Questions concerning the role of apraclonidine in the management of glaucoma.
    Robin AL
    Arch Ophthalmol; 1995 Jun; 113(6):712-4. PubMed ID: 7786208
    [No Abstract]   [Full Text] [Related]  

  • 39. Apraclonidine and argon laser trabeculoplasty.
    Ofner S; Samples JR; van Buskirk EM
    Am J Ophthalmol; 1992 Dec; 114(6):778-9. PubMed ID: 1361104
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.